Literature DB >> 2428099

Some clinical aspects of uroflowmetry in elderly males. A population survey.

K M Jensen, J B Jørgensen, P Mogensen, N E Bille-Brahe.   

Abstract

A random sample of 200 males aged 50 years or more was selected from the National Register in order to investigate various aspects of spontaneous uroflowmetry and to estimate the frequency of prostatism and symptoms of lower urinary tract dysfunction. All in all the data from 112 persons were analysed. The prevalence of prostatism was found to be 17% (95% confidence limits 11-26%), while 88% (95% confidence limits 83-95%) experienced various degrees of symptoms. Only few associations between single symptoms and uroflowmetry variables were demonstrated. However, statistically significant correlations were revealed between obstructive and total symptom scores on one hand and maximum and average flow rates on the other hand. As the correlations were modest and a considerable overlap of uroflow variables in persons with and without prostatism were proved, the diagnostic specificity and sensitivity of maximum flow rate as well as other uroflow variables were low in the screening for prostatism. In conclusion uroflowmetry appears inefficient to confirm a clinical impression of prostatism.

Entities:  

Mesh:

Year:  1986        PMID: 2428099     DOI: 10.3109/00365598609040555

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  8 in total

1.  Underdetection of clinical benign prostatic hyperplasia in a general medical practice.

Authors:  M F Collins; R H Friedman; A Ash; R Hall; M A Moskowitz
Journal:  J Gen Intern Med       Date:  1996-09       Impact factor: 5.128

Review 2.  Benign prostatic hyperplasia.

Authors:  R J Simpson
Journal:  Br J Gen Pract       Date:  1997-04       Impact factor: 5.386

3.  Late renal failure due to prostatic outflow obstruction: a preventable disease.

Authors:  S H Sacks; S A Aparicio; A Bevan; D O Oliver; E J Will; A M Davison
Journal:  BMJ       Date:  1989-01-21

Review 4.  Urodynamics of the lower urinary tract.

Authors:  K T Nielsen; R C Bruskewitz; P O Madsen
Journal:  Urol Res       Date:  1988

Review 5.  Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective.

Authors:  L M Eri; K J Tveter
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

6.  Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men.

Authors:  W M Garraway; E B Russell; R J Lee; G N Collins; G B McKelvie; M Hehir; A C Rogers; R J Simpson
Journal:  Br J Gen Pract       Date:  1993-08       Impact factor: 5.386

7.  Factors influencing nonabsolute indications for surgery in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: analysis using causal bayesian networks.

Authors:  Myong Kim; Luis Ramirez; Changwon Yoo; Minsoo Choo; Jae-Seung Paick; Seung-June Oh
Journal:  Int Neurourol J       Date:  2014-12-29       Impact factor: 2.835

Review 8.  The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys.

Authors:  Wenying Wang; Yuwen Guo; Daoxin Zhang; Ye Tian; Xiaonan Zhang
Journal:  Sci Rep       Date:  2015-08-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.